MyLymphomaTeam

Angioimmunoblastic T-cell lymphoma (AITL) is a fast-growing type of cancer that primarily affects the lymph nodes and bone marrow, and can also impact the liver and spleen. It's closely related to follicular T-cell lymphoma (FTCL), and both conditions are treated similarly. The main treatment approach is chemotherapy, which Show Full Answer

Angioimmunoblastic T-cell lymphoma (AITL) is a fast-growing type of cancer that primarily affects the lymph nodes and bone marrow, and can also impact the liver and spleen. It's closely related to follicular T-cell lymphoma (FTCL), and both conditions are treated similarly. The main treatment approach is chemotherapy, which can be used alone or combined with targeted drug therapy. Some patients may receive high-dose chemotherapy or radiation followed by a stem cell transplant. The good news is that chemotherapy has a high response rate of 70-80 percent. Regarding prognosis, stem cell transplantation can improve outcomes, increasing the five-year progression-free survival rate to 40 percent. Most people are diagnosed in advanced stages (3 or 4), which means the cancer has spread to both sides of the diaphragm and may include organs outside of the lymphatic system.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Angioimmunoblastic T-Cell Lymphoma — An Overview